3’s, a Life’s on the line – sometime’s convenience isn’t the 1st priority. I’d at least take a look at the India Ph.2 trial…
“Open-Label, Dose Confirmation Study of Interstitial 131I-chTNT-1/B MAb (Cotara) for the Treatment of Glioblastoma Multiforme (GBM) at First Relapse” This study is currently recruiting participants. http://clinicaltrials.gov/ct2/show/NCT00677716